ARCHIVES

Cancer Centers Win Majority Of Grants In Recent NCI RFAs, Klausner Tells AACI.

This article is from The Cancer Letter archive.

Vol. 26 No. 36 | October 6, 2000

Download PDF Visit The Full Archive

Related Articles

Yervoy-Nivolumab Combination Treatment Shrinks Tumors 80 Percent in Three Months

May 31, 2013

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

July 14, 2006

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

Nexavar Approved For Patients With Inoperable Liver Cancer

November 30, 2007

In Brief: McDonnell Foundation Selects Five For Awards; James Benson Is Named Interim FDA Head

November 24, 1989

ACCC Considers Role Of Allied Personnel, Funds, Center Components

February 13, 1976